Silexion Therapeutics Corp Ordinary Shares (SLXN) Dividend History

Silexion Therapeutics Corp is a biopharmaceutical company focused on developing innovative therapies for rare and underserved diseases. The company leverages advanced research and development to create targeted treatments with the aim to improve patient outcomes.

2 Hamayan Street, Modiin-Maccabim-Reut, L3, 7177871
Phone: 972-8-6286005
Website: https://www.silexion.com

Dividend History

Silexion Therapeutics Corp Ordinary Shares currently does not pay dividends

Company News

Silexion Therapeutics Announces Exercise of Warrants for $3.3 Million Gross Proceeds

Silexion Therapeutics, a clinical-stage biotech company, announced the exercise of outstanding warrants for $3.3 million in gross proceeds. The company plans to use the funds for general corporate purposes.

GlobeNewswire Inc.
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings

U.S. stock futures were mixed ahead of the Federal Reserve's interest rate decision and key earnings reports from major tech companies. Investors are cautious as they await the Fed's policy announcement and guidance.

Benzinga

Featured Companies: BNZI META MSFT QQQ SBUX SPY SXTP SYK TSLA
Silexion Therapeutics Announces 1-for-9 Reverse Share Split

Silexion Therapeutics, a clinical-stage biotech company, announced a 1-for-9 reverse share split to maintain its Nasdaq listing and support its strategic growth initiatives. The reverse split is expected to help the company comply with Nasdaq requirements and enhance its market position.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 12:27:08 UTC